Analysis of data from 41 health care systems participating in the PCORnet, the National
Patient-Centered Clinical Research Network found lower use of monoclonal antibody …

Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 ― United States, January–July
2022 | MMWR Skip directly to site content Skip directly to search Español | Other Languages …

Background: The coronavirus disease 2019 (COVID-19) pandemic has exposed
longstanding racial and ethnic inequities in health risks and outcomes in the United States …

Importance Several pharmacotherapies have been authorized to treat nonhospitalized
persons with symptomatic COVID-19. Longitudinal information on the use of these therapies …

With the continuing coronavirus disease 2019 (COVID-19) pandemic coupled with phased
reopening, it is critical to identify risk factors associated with susceptibility and severity of …

Background: The COVID-19 pandemic has caused substantial morbidity and mortality.
Objective: To describe monthly clinical trends among adults hospitalized with COVID-19 …

Within each US Census region, the proportion of hospitalized patients with COVID-19 was
highest for Hispanic or Latino patients. Racial and ethnic disparities were largest during May …

Racial Disproportionality in Covid Clinical Trials To provide the necessary data for
generalizing efficacy and safety outcomes across racial groups, Covid-19 clinical trials must …

Background Racial/ethnic disparities in disease burden have gained the spotlight in the
United States with the spread of SARS-CoV-2 and surge of COVID-19 cases. The problem of …

Importance Racial and ethnic minority groups are disproportionately affected by COVID-19.
Objectives To evaluate whether rates of severe COVID-19, defined as hospitalization …